ストックスクリーナーアプリを入手
7.65
4.37%
-0.35
前日終値:
$8.00
開ける：
$8.03
24時間の取引高:
81,348
Relative Volume:
1.51
時価総額：
$299.42M
収益：
$4.71M
当期純損益:
$-46.77M
株価収益率:
-4.5557
EPS:
-1.6792
ネットキャッシュフロー:
$-60.34M
1週間 パフォーマンス:
-32.66%
1か月 パフォーマンス:
-25.37%
6か月 パフォーマンス:
-21.13%
1年 パフォーマンス:
-43.29%
1日の値動き範囲:
$7.41
$8.08
1週間の範囲:
$7.41
$11.87
52週間の値動き範囲:
$6.76
$13.50
Nyxoah Sa Stock (NYXH) Company Profile
NYXH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
7.65 | 299.42M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
491.84 | 181.97B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.50 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
95.77 | 47.37B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
219.94 | 32.31B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
33.75 | 17.31B | 17.28B | 108.00M | 391.00M | 0.20 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-31 | 開始されました | H.C. Wainwright | Buy |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2022-04-21 | 開始されました | Oppenheimer | Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2021-12-21 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-07-28 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Nyxoah Sa (NYXH) 最新ニュース
HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World
Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull
Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks
Nyxoah Says FDA Issues Approvable Letter for Genio System - Marketscreener.com
FDA Issues Approvable Letter For Nyxoah's Genio® System - TradingView
FDA Clears Path Forward for Nyxoah's Revolutionary Sleep Apnea Treatment - StockTitan
Stifel Nicolaus Has Lowered Expectations for Nyxoah (NASDAQ:NYXH) Stock Price - Defense World
Stifel cuts Nyxoah stock price target to $15, maintains Buy By Investing.com - Investing.com Canada
Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates - MSN
(NYXH) Investment Analysis - Stock Traders Daily
Stifel cuts Nyxoah stock price target to $15, maintains Buy - Investing.com
Nyxoah S.A. (NASDAQ:NYXH) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy on Nyxoah shares, $17 target - Investing.com
Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ... By GuruFocus - Investing.com Canada
Nyxoah Reports 2024 Financial Results and U.S. Launch Plans - TipRanks
Nyxoah Sa’s Earnings Call: Efficacy and Expansion - TipRanks
Nyxoah Reports Strong Q4 Growth as Sleep Apnea Device Nears FDA Green Light - StockTitan
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - Yahoo Finance
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - The Manila Times
Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World
Nyxoah (NYXH) to Release Quarterly Earnings on Thursday - Defense World
Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz
(NYXH) Investment Report - Stock Traders Daily
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - The Manila Times
Sleep Apnea Innovator Nyxoah Takes Center Stage at Major Healthcare Conference - StockTitan
Nyxoah (NYXH) to Release Quarterly Earnings on Tuesday - Defense World
Nyxoah (NYXH) Projected to Post Earnings on Tuesday - MarketBeat
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) versus Nyxoah (NASDAQ:NYXH) Critical Review - Defense World
(NYXH) On The My Stocks Page - Stock Traders Daily
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewswire
Revolutionary Sleep Apnea Treatment Crosses Borders: Inside Genio's Middle East Launch - StockTitan
Nyxoah Launches Genio Therapy in Middle East with First UAE Implantation - TipRanks
Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat
Tri Pointe Homes (TPH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Nyxoah (NASDAQ:NYXH) Shares Up 0.6% – Here’s What Happened - Defense World
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Environmental Expert
(NYXH) Trading Report - Stock Traders Daily
Trend Tracker for (NYXH) - Stock Traders Daily
Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah Receives Transparency Notification from BlackRock - TipRanks
Publication relating to transparency notifications - GlobeNewswire
BlackRock Reduces Stake in Nyxoah Below 3% Threshold in Latest Holdings Update - StockTitan
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
(NYXH) Proactive Strategies - Stock Traders Daily
Retail investors are Nyxoah S.A.'s (EBR:NYXH) biggest owners and were rewarded after market cap rose by €38m last week - Simply Wall St
Nyxoah Sa (NYXH) 財務データ
収益
当期純利益
現金流量
EPS
3.09%
0.06%
大文字化:
|
ボリューム (24 時間):